Independent Director's 2025 Annual Work Report
As an independent director of Beijing Saisheng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company"), I, Liu Feng, have strictly adhered to the provisions and requirements of the Company Law, Securities Law, and relevant regulatory documents, as well as the Company's Articles of Association and Independent Director Work System. With a commitment to all shareholders, I have diligently and faithfully fulfilled my duties as an independent director, providing objective, prudent, and fair independent opinions on significant matters, actively safeguarding the interests of the Company and its shareholders, especially minority shareholders, and effectively performing the roles of independent director and committee member of the board.
I. Basic Information of the Independent Director
(1) Work Experience, Professional Background, and Concurrent Positions
Liu Feng, male, born in November 1986, Chinese nationality, no permanent residency abroad, holds a bachelor's degree in law. Graduated from Jilin University with degrees in Clinical Medicine (Medical Jurisprudence), Business Administration, and obtained bachelor's degrees in Law, Medicine, and Management. From 2011 to 2013, worked as a lawyer at Beijing Xiongzhi Law Firm, and since 2013, has been a partner lawyer at Beijing Zhongwen Law Firm, providing professional legal services in corporate legal risk control, intellectual property, health, and commercial dispute resolution for medium and large enterprises. Currently serves as the chairman of the Health Rights Protection Committee of the Bethune Public Welfare Foundation, a director of the Chinese Society of Health Law, a special researcher at the Chinese Academy of Management Sciences, and a member of the Medical and Health Law Professional Committee of the Beijing Lawyers Association, among other positions. Has served as an independent director of the Company since January 26, 2024.
(2) Independence Statement
During my tenure as an independent director, I have not held any position in the Company other than that of independent director, nor have I held any position in the Company's major shareholders. There are no relationships that hinder my ability to make independent and objective judgments, and I meet the independence requirements outlined in the relevant laws, regulations, and the Company's Articles of Association.
II. Annual Performance Overview of the Independent Director
(1) Attendance at Board and Shareholder Meetings
In 2025, the Company held a total of 7 board meetings, and I attended all of them in person without delegating my voting rights to other independent directors. I carefully reviewed all proposals submitted to the board, maintained sufficient communication with the management, actively participated in discussions, and provided reasonable suggestions, exercising my voting rights with a cautious and responsible attitude. I believe that the convening and holding of the board meetings complied with legal procedures, and all significant matters followed the relevant approval processes, being legal and effective without harming the interests of the Company and all shareholders. Therefore, I voted in favor of all proposals and other matters presented to the board in 2025, with no objections or abstentions. The Company held 3 shareholder meetings in 2025, and I attended all of them in person.